TCR-ENGINEERED T CELL IMMUNOTHERAPY FOR EPITHELIAL OVARIAN CANCER ENHANCED BY TGFBETA BLOCKAGE AND EPIGENETIC MODULATION

Health Research, Inc., Rockville MD

Investigators